Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium
- 1 April 2003
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 3 (4) , 241-249
- https://doi.org/10.1016/s1473-3099(03)00581-4
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Antibiotics in agriculture: When is it time to close the barn door?Proceedings of the National Academy of Sciences, 2002
- Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteriaProceedings of the National Academy of Sciences, 2002
- Understanding the Spread of Antibiotic Resistant Pathogens in Hospitals: Mathematical Models as Tools for ControlClinical Infectious Diseases, 2001
- Emergence of Vancomycin-Resistant EnterococciEmerging Infectious Diseases, 2001
- In vitro susceptibility of Enterococcus faecium isolated from food to growth-promoting and therapeutic antibioticsInternational Journal of Food Microbiology, 2000
- The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptionsProceedings of the National Academy of Sciences, 2000
- Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programsProceedings of the National Academy of Sciences, 1999
- Transmission Dynamics of Epidemic Methicillin‐ResistantStaphylococcus aureusand Vancomycin‐Resistant Enterococci in England and WalesThe Journal of Infectious Diseases, 1999
- The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistanceProceedings of the National Academy of Sciences, 1999
- Occurrence and epidemiology of resistance to virginiamycin and streptograminsJournal of Antimicrobial Chemotherapy, 1999